Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 13, 2025

Total Value ($000): $246,761 (100.0% shares, 0.0% debt)

Holdings (24)

JAZZ JAZZ PHARMACEUTICALS PLC 8.9%
Value ($000) $21,962 Shares 206,952 Est. Cost $108.63 Unrealized 0.0%
IRON DISC MEDICINE INC 8.5%
Value ($000) $20,978 Shares 396,115 Est. Cost $47.97 Unrealized -2.1%
AMLX AMYLYX PHARMACEUTICALS INC 8.5%
Value ($000) $20,900 Shares 3,260,570 Est. Cost $4.21 Unrealized +15.7%
PCVX VAXCYTE INC 7.2%
Value ($000) $17,693 Shares 544,221 Est. Cost $48.83 Unrealized -32.9%
COGT COGENT BIOSCIENCES INC 6.7%
Value ($000) $16,496 Shares 2,297,524 Est. Cost $7.59 Unrealized -27.0%
CELC CELCUITY INC 6.4%
Value ($000) $15,827 Shares 1,185,520 Est. Cost $15.84 Unrealized -31.3%
CGON CG ONCOLOGY INC 6.2%
Value ($000) $15,253 Shares 586,647 Est. Cost $34.79 Unrealized -30.7%
XENE XENON PHARMACEUTICALS INC 5.9%
Value ($000) $14,660 Shares 468,364 Est. Cost $39.67 Unrealized -17.8%
DYN DYNE THERAPEUTICS INC 5.6%
Value ($000) $13,856 Shares 1,455,429 Est. Cost $11.01 Unrealized 0.0%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.6%
Value ($000) $13,725 Shares 290,784 Est. Cost $47.43 Unrealized -14.1%
MERUS N V 4.8%
Value ($000) $11,796 Shares 224,260 Est. Cost $35.99 Unrealized
CNTA CENTESSA PHARMACEUTICALS PLC 4.2%
Value ($000) $10,424 Shares 793,327 Est. Cost $13.84 Unrealized
LENZ LENZ THERAPEUTICS INC 4.1%
Value ($000) $10,033 Shares 342,312 Est. Cost $27.20 Unrealized 0.0%
NBIX NEUROCRINE BIOSCIENCES INC 3.0%
Value ($000) $7,313 Shares 58,181 Est. Cost $114.68 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 2.7%
Value ($000) $6,761 Shares 728,576 Est. Cost $8.25 Unrealized -5.2%
ASND ASCENDIS PHARMA A/S 2.7%
Value ($000) $6,592 Shares 38,191 Est. Cost $128.89 Unrealized
ARGX ARGENX SE 2.3%
Value ($000) $5,669 Shares 10,285 Est. Cost $394.09 Unrealized
ABVX ABIVAX SA 1.9%
Value ($000) $4,762 Shares 622,479 Est. Cost $13.48 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.9%
Value ($000) $4,688 Shares 500,551 Est. Cost $18.17 Unrealized -39.4%
NAMS NEWAMSTERDAM PHARMA COMPANY 1.6%
Value ($000) $3,997 Shares 220,695 Est. Cost $19.89 Unrealized -8.3%
CTNM CONTINEUM THERAPEUTICS INC 0.5%
Value ($000) $1,268 Shares 319,348 Est. Cost $15.90 Unrealized -72.7%
REPL REPLIMUNE GROUP INC 0.5%
Value ($000) $1,198 Shares 128,917 Est. Cost $8.73 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 0.3%
Value ($000) $710 Shares 62,793 Est. Cost $7.51 Unrealized +62.7%
SLN SILENCE THERAPEUTICS PLC 0.1%
Value ($000) $201 Shares 34,737 Est. Cost $11.10 Unrealized